๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Solid Tumour

A Phase I Study of ABSK211 in Participants With Advanced Solid Tumors With KRAS Alteration NCT07718165Phase 11 site๐Ÿ“ Shanghai Abbisko Therapeutics Co, Ltd ยท Tests: ABSK211 A First-in-Human Study of BG-C0979 in Adults With Advanced Solid Tumors NCT07414836Phase 118 sites๐Ÿ“ Boston๐Ÿ“ St Louis๐Ÿ“ Hackensack BeOne Medicines ยท Tests: BG-C0979, Tislelizumab Dose-escalation Study to Assess Safety and Pharmacokinetics of Nab-Sirolimus in Patients With Locally Advanced or Metastatic Solid Tumors and Moderate Liver Impairment NCT05661461Phase 12 sites๐Ÿ“ San Antonio๐Ÿ“ West Valley City Aadi Bioscience, Inc. ยท Tests: nab-sirolimus A Study to Assess the Safety and Efficacy of LB1410 in Participants With Advanced Solid Tumor or Lymphoma๏ผˆKeyplus-001๏ผ‰ NCT05357651Phase 11 site๐Ÿ“ Shanghai L & L Bio Co., Ltd., Ningbo, China ยท Tests: LB1410 A Study of BL-M05D1 in Patients With Locally Advanced or Metastatic Solid Tumors NCT06349811Phase 11 site๐Ÿ“ Beijing Sichuan Baili Pharmaceutical Co., Ltd. ยท Tests: BL-M05D1 AI-Assisted Chemotherapy Side Effect Management NCT07198581NA1 site๐Ÿ“ Incheon Incheon St.Mary's Hospital ยท Tests: LLM-assisted chemotherapy side effect management An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors NCT07222267Phase 132 sites๐Ÿ“ Birmingham๐Ÿ“ New Haven๐Ÿ“ St Louis BeOne Medicines ยท Tests: BG-75202, CDK4 Inhibitor, Estrogen Receptor Antagonist, Aromatase Inhibitor Study in Children and Adolescents of 177Lu-DOTATATE (Lutatheraยฎ) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed). NCT06607692Phase 1, Phase 21 site๐Ÿ“ Boadilla del Monte Fundaciรณn de investigaciรณn HM ยท Tests: Olaparib; 177Lu-DOTATATE A Study of Almonertinib Combined With Palbociclib in Patients With Advanced Solid Tumors Harboring KRAS Mutations NCT06947811Phase 1, Phase 21 site๐Ÿ“ Guangzhou Sun Yat-sen University ยท Tests: Almonertinib, Palbociclib MT027 in Patients With Advanced Peritoneal Malignancies or Abdominal Metastatic Solid Tumors NCT06912152Phase 11 site๐Ÿ“ Hangzhou Zhejiang University ยท Tests: MT027 CAR-T cells ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR) NCT06415487Phase 19 sites๐Ÿ“ San Diego๐Ÿ“ Denver๐Ÿ“ Nashville Acepodia Biotech, Inc. ยท Tests: Cyclophosphamide, Fludarabine, ACE2016, Pembrolizumab Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC NCT06162221Phase 1, Phase 298 sites๐Ÿ“ Gilbert๐Ÿ“ Duarte๐Ÿ“ Irvine Revolution Medicines, Inc. ยท Tests: RMC-6291, RMC-6236, Pembrolizumab, Cisplatin, Carboplatin Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors NCT04557449Phase 1, Phase 239 sites๐Ÿ“ Los Angeles๐Ÿ“ New Haven๐Ÿ“ New Haven Pfizer ยท Tests: PF-07220060, Letrozole, Fulvestrant, Midazolam, Enzalutamide A Phase I Study of HS-20108 in Participants With Advanced Solid Tumors NCT06936735Phase 11 site๐Ÿ“ Shanghai Hansoh BioMedical R&D Company ยท Tests: HS-20108 Monotherapy Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8008 for Injection NCT05620017Phase 12 sites๐Ÿ“ Chongqing๐Ÿ“ Hangzhou Bio-Thera Solutions ยท Tests: BAT8008 for Injection A Clinical Trial of MK-2010 With Sacituzumab Tirumotecan (Sac-TMT) in Participants With Solid Tumors (MK-2010) NCT07785609Phase 24 sites๐Ÿ“ San Antonio๐Ÿ“ Hong Kong๐Ÿ“ Bellinzona Merck Sharp & Dohme LLC ยท Tests: MK-2010, Sacituzumab tirumotecan, Histamine H1 Receptor Antagonist, Histamine H2 Receptor Antagonist, Acetaminophen (orโ€ฆ A Study to Investigate ANS03 in Participants With Locally Advanced or Metastatic Solid Tumors NCT06716138Phase 15 sites๐Ÿ“ New York๐Ÿ“ Fuzhou๐Ÿ“ Guangzhou Avistone Biotechnology Co., Ltd. ยท Tests: ANS03 A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies NCT04678648Phase 13 sites๐Ÿ“ Los Angeles๐Ÿ“ Denver๐Ÿ“ Nashville RasCal Therapeutics, Inc. ยท Tests: RSC-1255 Dose Escalation, RSC-1255 Dose Expansion A Study of GNC-077 in Patients With Locally Advanced or Metastatic Breast Cancer and Other Solid Tumors NCT06609187Phase 11 site๐Ÿ“ Beijing Sichuan Baili Pharmaceutical Co., Ltd. ยท Tests: GNC-077 A Clinical Study of SPH7485 Tablets in the Treatment of Advanced Solid Tumors. NCT06487455Phase 16 sites๐Ÿ“ Changsha๐Ÿ“ Fuzhou๐Ÿ“ Hangzhou Shanghai Pharmaceuticals Holding Co., Ltd ยท Tests: SPH7485 Increasing Knowledge and Interest in Cancer Clinical Trials NCT06501040NA1 site๐Ÿ“ Detroit Hayley Thompson ยท Tests: Web-based Educational Intervention, Questionnaire Administration PRO-BOOST-LC: Whole-Gland Boost Strategies Versus SBRT Monotherapy in PSMA-Staged Localized and Locally Advanced Prostate Cancer NCT07426055Phase 2, Phase 31 site๐Ÿ“ Zamoล›ฤ‡ Affidea Nu-med Center of Oncological DIagnostics and Therapy ยท Tests: Stereotactic Body Radiotherapy (SBRT) Monotherapy, External Beam Radiotherapy (EBRT) Backbone, High-Dose-Rate Brachytheโ€ฆ COAST Therapy in Advanced Solid Tumors and Prostate Cancer NCT05036226Phase 1, Phase 21 site๐Ÿ“ Charleston Medical University of South Carolina ยท Tests: Hydroxychloroquine, Metformin, Sirolimus, Hydroxychloroquine, Metformin, Sirolimus, Dasatanib, Hydroxychloroquine, Metfโ€ฆ Trop2-targeted immunoPET Imaging of Solid Tumors NCT06851663Phase 2, Phase 31 site๐Ÿ“ Shanghai RenJi Hospital ยท Tests: [68Ga]Ga-NOTA-T4, [68Ga]Ga-NOTA-RT4, [18F]F-RESCA-T4, [18F]F-RESCA-RT4 Testing How the Body Responds to the Drug CX-5461 (Pidnarulex) in Patients With Metastatic Solid Cancers NCT06606990Phase 11 site๐Ÿ“ Bethesda National Cancer Institute (NCI) ยท Tests: Biopsy Procedure, Biospecimen Collection, Computed Tomography, Echocardiography Test, Magnetic Resonance Imaging A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors NCT05836324Phase 139 sites๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles๐Ÿ“ Boston Incyte Corporation ยท Tests: INCA33890, bevacizumab, FOLFIRI, FOLFOX, Cetuximab Personalized Neoantigen Peptide Vaccines for Solid Tumors NCT07002203Phase 1, Phase 21 site๐Ÿ“ Bangkok Seqker Biosciences, Inc. ยท Tests: Personalized Neoantigen Peptide Vaccine CW-301 FIH Study of CAN016 NCT07664150Phase 1, Phase 21 site๐Ÿ“ Beijing Canwell Biotech Limited ยท Tests: CAN016, CAN016 A Biospecimen Collection Study of Leukapheresis-Derived Circulating Tumor Cells, Immune Cells, and Progenitor Cells. NCT00571389n/a1 site๐Ÿ“ Huntersville BioCytics, Inc. REStoring lymphoCytes Using NKTR-255* After chemoradiothErapy in Solid Tumors (RESCUE) NCT05632809Phase 21 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: NKTR-255, Durvalumab
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy